本文選題：心肌梗死 + 醫(yī)院死亡率��； 參考：《解放軍醫(yī)學(xué)雜志》2016年06期

【摘要】：預(yù)測(cè)ST段抬高型心肌梗死(STEMI)患者院內(nèi)死亡風(fēng)險(xiǎn)對(duì)于指導(dǎo)臨床醫(yī)生選擇合理治療方案至關(guān)重要。本期刊登的四篇文章深入分析了近年我國(guó)軍隊(duì)醫(yī)院冠心病介入治療數(shù)據(jù)庫(kù)的資料,分別從性別、心肌梗死靶血管術(shù)前閉塞程度、單中心規(guī)范化胸痛中心建設(shè)、應(yīng)用主動(dòng)脈內(nèi)球囊反搏治療方面探討了STEMI患者院內(nèi)死亡的影響因素,這將有助于臨床醫(yī)生制定個(gè)體化治療方案、進(jìn)一步優(yōu)化再灌注策略、提高臨床療效和改善患者預(yù)后。
[Abstract]:Predicting the risk of hospital death in patients with ST-segment elevation myocardial infarction (STEMI) is essential to guide clinicians to choose a reasonable treatment plan. Four articles published in this issue have thoroughly analyzed the data of coronary intervention treatment database in military hospitals in China in recent years, from gender, degree of occlusion of target vessels in myocardial infarction before operation, construction of standardized chest pain center with single center. In the aspect of intra-aortic balloon counterpulsation, the factors influencing hospital mortality in patients with STEMI were discussed, which would be helpful for clinicians to formulate individualized treatment plan, further optimize reperfusion strategy, improve clinical efficacy and improve prognosis of patients.
【作者單位】： 沈陽(yáng)軍區(qū)總醫(yī)院全軍心血管病研究所心內(nèi)科;
【分類(lèi)號(hào)】：R542.22
，

本文編號(hào)：1843001